Human papillomavirus vaccine efficacy and effectiveness against cancer

S Kamolratanakul, P Pitisuttithum - Vaccines, 2021 - mdpi.com
Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Cervical cancer immunotherapy: facts and hopes

L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu - Clinical Cancer Research, 2021 - AACR
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Viral oncology: molecular biology and pathogenesis

UN Mui, CT Haley, SK Tyring - Journal of clinical medicine, 2017 - mdpi.com
Oncoviruses are implicated in approximately 12% of all human cancers. A large number of
the world's population harbors at least one of these oncoviruses, but only a small proportion …

A natural isoquinoline alkaloid with antitumor activity: studies of the biological activities of berberine

D Liu, X Meng, D Wu, Z Qiu, H Luo - Frontiers in pharmacology, 2019 - frontiersin.org
Coptis, a traditional medicinal plant, has been used widely in the field of traditional Chinese
medicine for many years. More recently, the chemical composition and bioactivity of Coptis …

[HTML][HTML] Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination …

HS Whitworth, KE Gallagher, N Howard… - Vaccine, 2020 - Elsevier
Objectives This study aimed to systematically review the literature on the efficacy and
immunogenicity of single-dose HPV vaccination compared to no vaccination or multi-dose …

Prevention, diagnosis and treatment of cervical cancer: a systematic review of the impact of COVID-19 on patient care

P Ferrara, G Dallagiacoma, F Alberti, L Gentile… - Preventive …, 2022 - Elsevier
Worldwide, the COVID-19 pandemic disrupted healthcare services, including cervical
cancer management, and an increased burden for this condition is expected. This …

Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage

JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

[HTML][HTML] Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews

A Villa, LL Patton, AR Giuliano, CG Estrich… - The Journal of the …, 2020 - Elsevier
Background This objective of this umbrella review was to summarize the evidence on safety,
efficacy, and effectiveness of human papillomavirus (HPV) vaccines in the general …

[HTML][HTML] Childhood vaccine coverage in Italy after the new law on mandatory immunization

C Signorelli, A Odone, P Cella, S Iannazzo - ANNALI DI IGIENE …, 2018 - iris.unisr.it
Background. The Italian National Immunization Prevention Plan (PNPV) identifies vaccines
actively offered free of charge to target populations within the National Health Service …

Therapeutic DNA vaccines for human papillomavirus and associated diseases

MA Cheng, E Farmer, C Huang, J Lin, CF Hung… - Human gene …, 2018 - liebertpub.com
Human papillomavirus (HPV) has long been recognized as the causative agent of cervical
cancer. High-risk HPV types 16 and 18 alone are responsible for over 70% of all cases of …